Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
Dimopoulos, Meletios, Weisel, Katja, Moreau, Philippe, Anderson, Larry D., White, Darrell, San-Miguel, Jesus, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Casal, Eva, Srinivasan, Shankar, Yu, Xin, Nguyen, Tuong Vi, Biyukov, Tsvetan, Peluso, Teresa, Richardson, Paul
Published in Leukemia (01.06.2021)
Published in Leukemia (01.06.2021)
Get full text
Journal Article
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population
Sørrig, Rasmus, Klausen, Tobias W, Salomo, Morten, Vangsted, Annette J, Frølund, Ulf Christian, Andersen, Kristian T, Klostergaard, Anja, Helleberg, Carsten, Pedersen, Robert S, Pedersen, Per T, Helm-Petersen, Sissel, Teodorescu, Elena Manuela, Preiss, Birgitte, Abildgaard, Niels, Gimsing, Peter
Published in PloS one (07.12.2017)
Published in PloS one (07.12.2017)
Get full text
Journal Article
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
Nielsen, Lene Kongsgaard, Stege, Claudia, Lissenberg-Witte, Birgit, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard, Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette, Deenik, Wendy, Coenen, Juleon, Hinge, Maja, Klein, Saskia, Tanis, Bea, Szatkowski, Damian, Brouwer, Rolf, Westerman, Matthijs, Leys, Rineke, Sinnige, Harm, Haukås, Einar, van der Hem, Klaas, Durian, Marc, Gimsing, Peter, van de Donk, Niels, Sonneveld, Pieter, Waage, Anders, Abildgaard, Niels, Zweegman, Sonja
Published in Haematologica (Roma) (01.06.2020)
Published in Haematologica (Roma) (01.06.2020)
Get full text
Journal Article
A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma
Hansson, Markus, Gimsing, Peter, Badros, Ashraf, Niskanen, Titti Martinsson, Nahi, Hareth, Offner, Fritz, Salomo, Morten, Sonesson, Elisabeth, Mau-Sorensen, Morten, Stenberg, Yvonne, Sundberg, Annika, Teige, Ingrid, Van Droogenbroeck, Jan, Wichert, Stina, Zangari, Maurizio, Frendeus, Björn, Korsgren, Magnus, Poelman, Martine, Tricot, Guido
Published in Clinical cancer research (15.06.2015)
Published in Clinical cancer research (15.06.2015)
Get full text
Journal Article
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population‐based study from the Danish national multiple myeloma registry
Redder, Louise, Klausen, Tobias W., Vangsted, Annette Juul, Gregersen, Henrik, Andersen, Niels F., Pedersen, Robert S., Szabo, Agoston G., Frederiksen, Mikael, Frølund, Ulf C., Helleberg, Carsten, Nielsen, Lene Kongsgaard, Pedersen, Per T., Salomo, Morten, Gimsing, Peter, Frederiksen, Henrik, Abildgaard, Niels
Published in British journal of haematology (01.04.2021)
Published in British journal of haematology (01.04.2021)
Get full text
Journal Article
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
Zweegman, Sonja, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard M.J., Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette W.G., Deenik, Wendy, Gruber, Astrid, Coenen, Juleon L.L.M., Plesner, Torben, Klein, Saskia K., Tanis, Bea C., Szatkowski, Damian L., Brouwer, Rolf E., Westerman, Matthijs, Leys, M.(Rineke) B.L., Sinnige, Harm A.M., Haukås, Einar, van der Hem, Klaas G., Durian, Marc F., Mattijssen, E.(Vera)J.M., van de Donk, Niels W.C.J., Stevens-Kroef, Marian J.P.L., Sonneveld, Pieter, Waage, Anders
Published in Blood (03.03.2016)
Published in Blood (03.03.2016)
Get full text
Journal Article
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial
Zweegman, Sonja, Stege, Claudia A M, Haukas, Einar, Schjesvold, Fredrik H, Levin, Mark-David, Waage, Anders, Leys, Rineke B L, Klein, Saskia K, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Knut-Bojanowska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Klostergaard, Anja, Salomo, Morten, Blimark, Celine, Ypma, Paula F, Mellqvist, Ulf-Henrik, Poddighe, Pino J, Stevens-Kroef, Marian, van de Donk, Niels W C J, Sonneveld, Pieter, Hansson, Markus, van der Holt, Bronno, Abildgaard, Niels
Published in Haematologica (Roma) (01.12.2020)
Published in Haematologica (Roma) (01.12.2020)
Get full text
Journal Article
Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study
Westin, Oscar, Butt, Jawad H, Gustafsson, Finn, Schou, Morten, Salomo, Morten, Køber, Lars, Maurer, Mathew, Fosbøl, Emil L
Published in JACC CardioOncology (01.10.2021)
Published in JACC CardioOncology (01.10.2021)
Get full text
Journal Article
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study
Sørrig, Rasmus, Klausen, Tobias W., Salomo, Morten, Vangsted, Annette J., Østergaard, Brian, Gregersen, Henrik, Frølund, Ulf Christian, Andersen, Niels F., Helleberg, Carsten, Andersen, Kristian T., Pedersen, Robert S., Pedersen, Per, Abildgaard, Niels, Gimsing, Peter
Published in European journal of haematology (01.09.2016)
Published in European journal of haematology (01.09.2016)
Get full text
Journal Article
Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry
Redder, Louise, Klausen, Tobias Wirenfeldt, Vangsted, Annette Juul, Gregersen, Henrik, Andersen, Niels Frost, Pedersen, Robert Schou, Plesner, Torben, Frederiksen, Mikael, Frølund, Ulf Christian, Helleberg, Carsten, Nielsen, Lene Kongsgaard, Salomo, Morten, Gimsing, Peter, Frederiksen, Henrik, Abildgaard, Niels
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial
Zweegman, Sonja, Stege, Claudia A M, Haukas, Einar, Schjesvold, Fredrik H, Levin, Mark-David, Waage, Anders, Leys, Rineke B L, Klein, Saskia K, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Knut-Bojanowska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Klostergaard, Anja, Salomo, Morten, Blimark, Celine, Ypma, Paula F, Mellqvist, Ulf-Henrik, Poddighe, Pino J, Stevens-Kroef, Marian, van de Donk, Niels W C J, Sonneveld, Pieter, Hansson, Markus, van der Holt, Bronno, Abildgaard, Niels
Published in Haematologica (Roma) (01.12.2020)
Published in Haematologica (Roma) (01.12.2020)
Get full text
Journal Article
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
Richardson, Paul G., Schjesvold, Fredrik, Weisel, Katja, Moreau, Philippe, Anderson, Larry D., White, Darrell, Rodriguez‐Otero, Paula, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Beksac, Meral, Oriol, Albert, Lindsay, Jindriska, Liberati, Anna Marina, Galli, Monica, Robak, Pawel, Larocca, Alessandra, Yagci, Munci, Vural, Filiz, Kanate, Abraham S., Jiang, Ruiyun, Grote, Lara, Peluso, Teresa, Dimopoulos, Meletios
Published in European journal of haematology (01.01.2022)
Published in European journal of haematology (01.01.2022)
Get full text
Journal Article
Pomalidomide + Bortezomib + Low-Dose Dexamethasone after 1 Prior Line of Therapy in Patients with Lenalidomide-Pretreated Multiple Myeloma: Subanalysis of the Phase 3 Optimismm Trial By Patient Age and Prior Stem Cell Transplant
Dimopoulos, Meletios A., Weisel, Katja C., Moreau, Philippe, Anderson, Larry D., White, Darrell J, San-Miguel, Jesús, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Casal, Eva, Jiang, Ruiyun, Srinivasan, Shankar, Nguyen, Tuong Vi, Biyukov, Tsvetan, Peluso, Teresa, Richardson, Paul G.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Two Decades of Cardiac Amyloidosis
Westin, Oscar, Butt, Jawad H., Gustafsson, Finn, Schou, Morten, Salomo, Morten, Køber, Lars, Maurer, Mathew, Fosbøl, Emil L.
Published in JACC CardioOncology (01.10.2021)
Published in JACC CardioOncology (01.10.2021)
Get full text
Journal Article
Pomalidomide + Bortezomib + Low-Dose Dexamethasone Vs Bortezomib + Low-Dose Dexamethasone As Second-Line Treatment in Patients with Lenalidomide-Pretreated Multiple Myeloma: A Subgroup Analysis of the Phase 3 Optimismm Trial
Dimopoulos, Meletios A, Weisel, Katja, Moreau, Philippe, Anderson, Larry, White, Darrell J, San-Miguel, Jesus F, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew W, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Yu, Xin, Nguyen, Tuong Vi, Bensmaine, Amine, Peluso, Teresa, Zaki, Mohamed, Richardson, Paul
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article